DiaMedica Therapeutics Inc（DMAC）價格預測DMACDiaMedica Therapeutics Inc

Alphio's DMAC stock price prediction model matches the current DiaMedica Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.88 (+1.80%). The 1-week path is $9.07 (+4.01%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

DiaMedica Therapeutics Inc (DMAC) is currently priced at $7.57, which is near its 200-day simple moving average of $7.081, indicating potential support. However, the stock has a low RSI of 37.218, suggesting it is oversold, yet it has also experienced a significant 9.12% drop over the past five days. The company's forward P/E ratio is 0, indicating no earnings expected in the near term, which raises concerns about its profitability. The main risk is the widening net loss reported for Q2 2026, which reached $10.1 million, up from $7.7 million the previous year, highlighting ongoing financial challenges.

DiaMedica Therapeutics Inc (DMAC) last closed at $8.72, gaining +1.04%. These facts feed the 1-day and 1-week DMAC price prediction above.